Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Clinical Kidney Journal|December 6, 2023
Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patientsLadan Zand, Fernando C Fervenza, Rosanna CoppoNeuroreport|January 27, 2005
Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampusLadan Zand, Jae K Ryu, James G McLarnonAdvances in Chronic Kidney Disease|March 8, 2014
Treatment of ANCA-associated vasculitis: new therapies and a look at old entitiesLadan Zand, Ulrich Specks, Sanjeev Sethi, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2023
Membranous nephropathy treatment standardYeshwanter Radhakrishnan, Ladan Zand, Sanjeev Sethi, et al.Clinical Nephrology|November 27, 2018
Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathyInsara Jaffer Sathick, Ladan Zand, Samih H Nasr, et al.Journal of Nephrology|February 7, 2014
Membranoproliferative glomerulonephritis associated with autoimmune diseasesLadan Zand, Fernando C Fervenza, Samih H Nasr, et al.Journal of the American Society of Nephrology : JASN|August 5, 2020
Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal GammopathyNattawat Klomjit, Nelson Leung, Fernando Fervenza, et al.Kidney International Reports|June 5, 2023
COVID-19 and Glomerular DiseasesNattawat Klomjit, Ladan Zand, Lynn D Cornell, et al.Clinical Kidney Journal|August 8, 2015
Lactate clearance and metabolic aspects of continuous high-volume hemofiltrationWisit Cheungpasitporn, Ladan Zand, John J Dillon, et al.Kidney Medicine|October 22, 2020
Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor-A Report of 3 CasesSandra M Herrmann, Mariam P Alexander, Michael F Romero, et al.Pageof 10